1251 - 1300 of 9118 Results
Title
Year
-
OPENTitle: Tackling a disease on a global scale, the Global Parkinson’s Genetics Program, GP2: A new generation of opportunitiesJournal Name: The American Journal of Human GeneticsPublisher: Elsevier BVVol: 112Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.ajhg.2025.07.014Best OA location URL: https://www.cell.com/ajhg/pdf/S0002-9297(25)00284-8.pdfCitation Count: 0
- Single-cell transcriptomics for immune profiling of cerebrospinal fluid in neurological diseases2025OPENTitle: Single-cell transcriptomics for immune profiling of cerebrospinal fluid in neurological diseasesJournal Name: Frontiers in ImmunologyPublisher: Frontiers Media SAVol: 16Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fimmu.2025.1599303Best OA location URL: https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1599303/pdfCitation Count: 0
-
OPENTitle: An unusual presentation of Huntington’s disease-like syndrome in a patient with Xeroderma pigmentosum type F: Case report and review of the literatureJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 12Issue #:Start Page: 100340End Page: 100340Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2025.100340Best OA location URL: https://doi.org/10.1016/j.prdoa.2025.100340Citation Count: 0
-
OPENTitle: a-synuclein PET Imaging: From Clinical Utility in Multiple System Atrophy to the Possible Diagnosis of Parkinson’s DiseaseJournal Name: CellsPublisher: MDPI AGVol: 14Issue #: 11Start Page: 834End Page: 834Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells14110834Best OA location URL: https://www.mdpi.com/2073-4409/14/11/834/pdf?version=1748956205Citation Count: 0
-
OPENTitle: Nigral diffusivity, but not free water, correlates with iron content in Parkinson’s diseaseJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 3Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcab251Best OA location URL: https://academic.oup.com/braincomms/article-pdf/3/4/fcab251/41152899/fcab251.pdfCitation Count: 10
-
OPENTitle: Physics of Protein Aggregation in Normal and Accelerated Brain AgingJournal Name: BioEssaysPublisher: WileyVol: 47Issue #: 8Start Page: e70030End Page: e70030Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/bies.70030Best OA location URL: https://doi.org/10.1002/bies.70030Citation Count: 3
-
OPENTitle: LRRK2 at Striatal Synapses: Cell-Type Specificity and Mechanistic InsightsJournal Name: CellsPublisher: MDPI AGVol: 11Issue #: 1Start Page: 169End Page: 169Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.3390/cells11010169Best OA location URL: https://www.mdpi.com/2073-4409/11/1/169/pdf?version=1641527866Citation Count: 34
- Intracellular Thermometry at the Micro‐/Nanoscale and its Potential Application to Study Protein Aggregation Related to Neurodegenerative Diseases2020RESTRICTEDTitle: Intracellular Thermometry at the Micro‐/Nanoscale and its Potential Application to Study Protein Aggregation Related to Neurodegenerative DiseasesJournal Name: ChemBioChemPublisher: WileyVol: 22Issue #: 9Start Page: 1546End Page: 1558Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/cbic.202000765Citation Count: 12
-
OPENTitle: Cholinergic system changes in Parkinson's disease: emerging therapeutic approachesJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 4Start Page: 381End Page: 392Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00377-xBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8985079Citation Count: 220
-
OPENTitle: A Review of RRx-001: A Late-Stage Multi-Indication Inhibitor of NLRP3 Activation and Chronic InflammationJournal Name: DrugsPublisher: Springer Science and Business Media LLCVol: 83Issue #: 5Start Page: 389End Page: 402Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s40265-023-01838-zBest OA location URL: https://link.springer.com/content/pdf/10.1007/s40265-023-01838-z.pdfCitation Count: 32
-
OPENTitle: Systematic Review on Parkinson’s Disease Medications, Emphasizing on Three Recently Approved Drugs to Control Parkinson’s SymptomsJournal Name: International Journal of Environmental Research and Public HealthPublisher: MDPI AGVol: 19Issue #: 1Start Page: 364End Page: 364Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijerph19010364Best OA location URL: https://www.mdpi.com/1660-4601/19/1/364/pdf?version=1641285359Citation Count: 67
-
OPENTitle: Clearing the Smoke: What Protects Smokers from Parkinson's Disease?Journal Name: Movement DisordersPublisher: WileyVol: 39Issue #: 2Start Page: 267End Page: 272Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29707Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29707Citation Count: 21
-
OPENTitle: Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as BiomarkersJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 4Start Page: 669End Page: 683Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28941Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28941Citation Count: 78
-
OPENTitle: Positron Emission Tomography Imaging in Clinical Trials for Parkinson's Disease: Applications of Metabolic Brain Network ApproachJournal Name: Movement DisordersPublisher: WileyVol: 40Issue #: 8Start Page: 1511End Page: 1527Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.30231Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.30231Citation Count: 0
-
OPENTitle: Constructing and exploring neuroimaging projects: a survey from clinical practice to scientific researchJournal Name: Insights into ImagingPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page: 272End Page: 272Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13244-024-01848-9Best OA location URL: https://insightsimaging.springeropen.com/counter/pdf/10.1186/s13244-024-01848-9Citation Count: 1
-
OPENTitle: Transcriptional landscape of human microglia implicates age, sex, and APOE‐related immunometabolic pathway perturbationsJournal Name: Aging CellPublisher: WileyVol: 21Issue #: 5Start Page: e13606End Page: e13606Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/acel.13606Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/acel.13606Citation Count: 52
-
OPENTitle: Radioligands Targeting the Purinergic P2X ReceptorsJournal Name: CellsPublisher: MDPI AGVol: 14Issue #: 13Start Page: 984End Page: 984Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells14130984Best OA location URL: https://www.mdpi.com/2073-4409/14/13/984/pdf?version=1751010309Citation Count: 0
- Practical pearls to improve the efficacy and tolerability of levodopa in Parkinson’s disease2022RESTRICTEDTitle: Practical pearls to improve the efficacy and tolerability of levodopa in Parkinson’s diseaseJournal Name: Expert Review of NeurotherapeuticsPublisher: Informa UK LimitedVol: 22Issue #: 6Start Page: 489End Page: 498Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/14737175.2022.2091436Citation Count: 15
-
OPENTitle: Therapeutic potential of autophagy-enhancing agents in Parkinson’s diseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page: 11End Page: 11Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-017-0154-3Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-017-0154-3Citation Count: 266
-
OPENTitle: Public Engagement and Neurology: An UpdateJournal Name: Brain SciencesPublisher: MDPI AGVol: 11Issue #: 4Start Page: 429End Page: 429Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci11040429Best OA location URL: https://www.mdpi.com/2076-3425/11/4/429/pdf?version=1617937511Citation Count: 7
-
OPENTitle: Initiation and propagation of α-synuclein aggregation in the nervous systemJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page: 19End Page: 19Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-020-00368-6Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-020-00368-6Citation Count: 245
-
OPENTitle: Rating Scales for Medication Adherence in Parkinson's Disease: A Systematic Review for Critique and RecommendationsJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: 2Start Page: 175End Page: 189Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13586Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9941935Citation Count: 6
- Waking up to the evidence of pharmacological treatments used to manage sleep disorders in people with dementia and mild cognitive impairment—A scoping review2025RESTRICTEDTitle: Waking up to the evidence of pharmacological treatments used to manage sleep disorders in people with dementia and mild cognitive impairment—A scoping reviewJournal Name: Pharmacological ReviewsPublisher: Elsevier BVVol: 78Issue #: 1Start Page: 100094End Page: 100094Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.pharmr.2025.100094Citation Count: 0
- Animal models in the study of Alzheimer's disease and Parkinson's disease: A historical perspective2022OPENTitle: Animal models in the study of Alzheimer's disease and Parkinson's disease: A historical perspectiveJournal Name: Animal Models and Experimental MedicinePublisher: WileyVol: 5Issue #: 1Start Page: 27End Page: 37Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ame2.12209Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ame2.12209Citation Count: 26
-
OPENTitle: Extracellular Vesicles as Novel Diagnostic and Prognostic Biomarkers for Parkinson’s DiseaseJournal Name: Aging and diseasePublisher: Aging and DiseaseVol: 12Issue #: 6Start Page: 1494End Page: 1494Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.14336/ad.2021.0527Best OA location URL: http://www.aginganddisease.org/EN/article/downloadArticleFile.do?attachType=PDF&id=148118Citation Count: 47
-
OPENTitle: Regulatory T cell α(1,3)-exofucosylation for treatment of neurodegenerative diseasesJournal Name: Journal of Leukocyte BiologyPublisher: Oxford University Press (OUP)Vol: 117Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/jleuko/qiaf154Best OA location URL: https://academic.oup.com/jleukbio/advance-article-pdf/doi/10.1093/jleuko/qiaf154/65038951/qiaf154.pdfCitation Count: 0
- Time for a New Image of Parkinson Disease2020RESTRICTEDTitle: Time for a New Image of Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 77Issue #: 11Start Page: 1345End Page: 1345Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2020.2412Citation Count: 45
-
OPENTitle: Glycopeptide drugs: A pharmacological dimension between “Small Molecules” and “Biologics”Journal Name: PeptidesPublisher: Elsevier BVVol: 131Issue #:Start Page: 170369End Page: 170369Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.peptides.2020.170369Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7448947Citation Count: 49
- β-adrenoreceptors and the risk of Parkinson's disease2020RESTRICTEDTitle: β-adrenoreceptors and the risk of Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 3Start Page: 247End Page: 254Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30400-4Citation Count: 73
-
OPENTitle: Nitric Oxide-Dependent Protein Post-Translational Modifications Impair Mitochondrial Function and Metabolism to Contribute to Neurodegenerative DiseasesJournal Name: Antioxidants & Redox SignalingPublisher: Mary Ann Liebert IncVol: 32Issue #: 12Start Page: 817End Page: 833Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1089/ars.2019.7916Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7074890Citation Count: 52
-
OPENTitle: Vesicle trafficking and lipid metabolism in synucleinopathyJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 141Issue #: 4Start Page: 491End Page: 510Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-020-02177-zBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7772270Citation Count: 43
-
OPENTitle: The multi‐faceted role of mitochondria in the pathology of Parkinson’s diseaseJournal Name: Journal of NeurochemistryPublisher: WileyVol: 156Issue #: 6Start Page: 715End Page: 752Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.15154Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.15154Citation Count: 66
-
OPENTitle: Probabilistic Modelling of Gait for Robust Passive Monitoring in Daily LifeJournal Name: IEEE Journal of Biomedical and Health InformaticsPublisher: Institute of Electrical and Electronics Engineers (IEEE)Vol: 25Issue #: 6Start Page: 2293End Page: 2304Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1109/jbhi.2020.3037857Best OA location URL: https://doi.org/10.1109/jbhi.2020.3037857Citation Count: 18
-
OPENTitle: Amyloid β, Tau, and α-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseasesJournal Name: Progress in NeurobiologyPublisher: Elsevier BVVol: 214Issue #:Start Page: 102270End Page: 102270Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.pneurobio.2022.102270Best OA location URL: https://doi.org/10.1016/j.pneurobio.2022.102270Citation Count: 217
- Motor and non-motor circuit disturbances in early Parkinson disease: which happens first?2021RESTRICTEDTitle: Motor and non-motor circuit disturbances in early Parkinson disease: which happens first?Journal Name: Nature Reviews NeurosciencePublisher: Springer Science and Business Media LLCVol: 23Issue #: 2Start Page: 115End Page: 128Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41583-021-00542-9Citation Count: 198
-
OPENTitle: Multi-layer Trajectory Clustering: a Network Algorithm for Disease SubtypingJournal Name: Biomedical Physics & Engineering ExpressPublisher: IOP PublishingVol: 6Issue #: 6Start Page: 065003End Page: 065003Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1088/2057-1976/abad8fBest OA location URL: http://export.arxiv.org/pdf/2005.14472Citation Count: 6
-
OPENTitle: Laboratory‐Supported Multiple System Atrophy beyond Autonomic Function Testing and Imaging: A Systematic Review by the MoDiMSA Study GroupJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 3Start Page: 322End Page: 340Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13158Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13158Citation Count: 13
-
OPENTitle: An Explainable Machine Learning Model for Early Detection of Parkinson's Disease using LIME on DaTSCAN ImageryJournal Name: Computers in Biology and MedicinePublisher: Elsevier BVVol: 126Issue #:Start Page: 104041End Page: 104041Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.compbiomed.2020.104041Best OA location URL: http://export.arxiv.org/pdf/2008.00238Citation Count: 193
- Neuroinflammation and Immune Changes in Prodromal Parkinson’s Disease and Other Synucleinopathies2022OPENTitle: Neuroinflammation and Immune Changes in Prodromal Parkinson’s Disease and Other SynucleinopathiesJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: s1Start Page: S149End Page: S163Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-223245Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd223245?id=journal-of-parkinsons-disease%2Fjpd223245Citation Count: 59
- Magnetic Resonance Imaging and Nuclear Imaging of Parkinsonian Disorders: Where do we go from here?2023OPENTitle: Magnetic Resonance Imaging and Nuclear Imaging of Parkinsonian Disorders: Where do we go from here?Journal Name: Current NeuropharmacologyPublisher: Bentham Science Publishers Ltd.Vol: 22Issue #: 10Start Page: 1583End Page: 1605Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2174/1570159x21666230801140648Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11284713Citation Count: 1
-
OPENTitle: Infection and Risk of Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 1Start Page: 31End Page: 43Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-202279Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd202279?id=journal-of-parkinsons-disease%2Fjpd202279Citation Count: 125
-
OPENTitle: Neuroprotektive Therapien bei idiopathischen, genetischen und atypischen Parkinson-Syndromen mit α-Synuklein – PathologieJournal Name: Der NervenarztPublisher: Springer Science and Business Media LLCVol: 92Issue #: 12Start Page: 1249End Page: 1259Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00115-021-01220-yBest OA location URL: https://pub.dzne.de/record/163370Citation Count: 4
- Human brain connectivity: Clinical applications for clinical neurophysiology2020RESTRICTEDTitle: Human brain connectivity: Clinical applications for clinical neurophysiologyJournal Name: Clinical NeurophysiologyPublisher: Elsevier BVVol: 131Issue #: 7Start Page: 1621End Page: 1651Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.clinph.2020.03.031Citation Count: 116
- Translating big data to better treatment in bipolar disorder - a manifesto for coordinated action2020OPENTitle: Translating big data to better treatment in bipolar disorder - a manifesto for coordinated actionJournal Name: European NeuropsychopharmacologyPublisher: Elsevier BVVol: 36Issue #:Start Page: 121End Page: 136Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.euroneuro.2020.05.006Best OA location URL: https://hdl.handle.net/11250/2729974Citation Count: 20
- Stem-Cell Research of Parkinson Disease: Bibliometric Analysis of Research Productivity from 1999 to 20182019RESTRICTEDTitle: Stem-Cell Research of Parkinson Disease: Bibliometric Analysis of Research Productivity from 1999 to 2018Journal Name: World NeurosurgeryPublisher: Elsevier BVVol: 134Issue #:Start Page: e405End Page: e411Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.wneu.2019.10.087Citation Count: 13
-
OPENTitle: LRRK2 and α-Synuclein: Distinct or Synergistic Players in Parkinson’s Disease?Journal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page: 577End Page: 577Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2020.00577Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2020.00577/pdfCitation Count: 70
- Error in Figure2021OPENTitle: Error in FigureJournal Name: JAMAPublisher: American Medical Association (AMA)Vol: 327Issue #: 1Start Page: 86End Page: 86Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jama.2021.16187Best OA location URL: https://jamanetwork.com/journals/jama/articlepdf/2787448/jama_2021_cx_210045_1640892482.39958.pdfCitation Count: 0
-
OPENTitle: Analysis of EEG Data Using Complex Geometric StructurizationJournal Name: Neural ComputationPublisher: MIT Press - JournalsVol: 33Issue #: 7Start Page: 1942End Page: 1969Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1162/neco_a_01398Best OA location URL: https://arxiv.org/pdf/2102.09061Citation Count: 5
-
OPENTitle: Targeting Mitochondrial Impairment in Parkinson's Disease: Challenges and OpportunitiesJournal Name: Frontiers in Cell and Developmental BiologyPublisher: Frontiers Media SAVol: 8Issue #:Start Page: 615461End Page: 615461Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fcell.2020.615461Best OA location URL: https://doi.org/10.3389/fcell.2020.615461Citation Count: 124
-
OPENTitle: Nucleic Acid–Based Therapeutics for Parkinson's DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 16Issue #: 2Start Page: 287End Page: 298Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s13311-019-00714-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-019-00714-7.pdfCitation Count: 52